ABBOTT LABORATORIES — Director's Dealing 2007

Aug 3, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-01

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-01	Common shares without par value	M	1436	$30.2428	Acquired	40168	Direct
2007-08-01	Common shares without par value	M	2881	$30.1958	Acquired	43049	Direct
2007-08-01	Common shares without par value	F	2572	$50.69	Disposed	40477	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-01	Option (right to buy)	$30.2428	M	1436	Disposed	2007-09-29	Common shares (1436)	Direct
2007-08-01	Option (right to buy)	$30.1958	M	2881	Disposed	2007-10-09	Common shares (2881)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1716	Indirect
Common shares without par value	732	Indirect

Footnotes

F1: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F2: The reporting person disclaims beneficial ownership of all securities held by her husband.

F3: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.